Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Pharmanest AB
Femme Max 99 ans
Pharmanest AB
MAJ Il y a 4 ans
An investigation of the feasibility of using a topical formulation of lidocaine (SHACT) for hysteroscopy in women
To obtain initial information regarding the feasibility of using SHACT as a formulation for hysteroscopy
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
Pharmanest AB
MAJ Il y a 4 ans
An open label pharmcokinetic study of a topical formulation of lidocaine (SHACT) for pain relief in women receiving an Intra Uterine Device
To establish the pharmacokinetic properties of SHACT including, AUC (0-120), Cmax and tmax, when applied in cervix and uterus of women receiving an IUD.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
Pharmanest AB
MAJ Il y a 4 ans
A randomized, double-blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study
To evaluate the maximum pain intensity experienced by the patient during and within 10 minutes after start of IUD insertion when treated with SHACT in comparison to placebo using a 100 mm VAS scale.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations